文献速递心脑血管急症重症综合管理与镇静镇痛

荷兰ICU收治肺栓塞患者的短期与长期死亡率

Short-Term and Long-Term Mortality of Pulmonary Embolism Patients Admitted to the ICU in the Netherlands.
PubMed 文献 · Crit Care Med · 2026-06-09
一句话结论荷兰全国ICU登记研究显示,高危肺栓塞患者住院死亡率25.4%,显著高于非高危患者的2.8%,且出院后1年死亡风险仍更高。

该回顾性队列研究基于荷兰重症监护评估登记处2013至2023年数据,纳入全部成年(≥18岁)以肺栓塞为ICU收治诊断的危重患者。主要终点为住院死亡率,次要终点为1年死亡率。10110例 eligible 患者中,1506例(14.6%)住院期间死亡。高危肺栓塞患者住院死亡率25.4%,高于非高危患者的2.8%。多变量分析显示高危患者1年死亡率也更高(HR 3.98;CI 3.59-4.40),出院后1年死亡率同样更高(HR 1.70;CI 1.49-1.96)。

要点

  • 荷兰全国ICU 2013至2023年以肺栓塞为收治诊断的成年(≥18岁)危重患者中,住院死亡1506例(14.6%)。
  • 高危肺栓塞患者住院死亡率25.4%,非高危患者2.8%。
  • 高危肺栓塞患者1年死亡率高于非高危患者(HR 3.98;CI 3.59-4.40)。
  • 出院后1年死亡率在高危肺栓塞患者中仍高于非高危患者(HR 1.70;CI 1.49-1.96)。
  • 作者认为,在肺栓塞患者管理决策时应考虑上述死亡数据。

适用人群与场景

  • 荷兰所有ICU中,2013至2023年间以肺栓塞为ICU收治诊断的成年(≥18岁)危重患者。

研究设计与关键结果

  • 研究类型:基于荷兰重症监护评估登记处的回顾性队列研究,覆盖荷兰所有ICU。
  • 纳入2013至2023年以肺栓塞为ICU收治诊断的成年(≥18岁)危重患者。
  • 10110例 eligible 患者中,1506例(14.6%)住院期间死亡。
  • 高危肺栓塞患者(n=1372)住院死亡率25.4%,非高危肺栓塞患者(n=134)住院死亡率2.8%。
  • 多变量分析显示,高危肺栓塞患者1年死亡率高于非高危患者(HR 3.98;CI 3.59-4.40)。
  • 出院后1年死亡率在高危肺栓塞患者中仍高于非高危患者(HR 1.70;CI 1.49-1.96)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(基于荷兰全国ICU登记处数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在肺栓塞患者管理决策时应考虑上述死亡数据。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To describe the short-term and long-term mortality of pulmonary embolism patients admitted to the ICU.

DESIGN: Retrospective cohort study of data from the Netherlands Intensive Care Evaluation registry.

SETTING: All ICUs in the Netherlands.

PATIENTS: All adult critically ill patients (≥ 18 yr) with pulmonary embolism as ICU admission diagnosis between 2013 and 2023 were included in the study.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The primary outcome is hospital mortality for patients with pulmonary embolism admitted to the ICU, as this represents short-term outcomes of pulmonary embolism and its treatment. The secondary outcome was 1-year mortality as a long-term outcome. Next, we compared patient characteristics and outcomes for survivors and nonsurvivors of the hospital admission. Of 10,210 eligible patients, 1,506 patients died (14.6%) during admission. This hospital mortality rate was higher in high-risk pulmonary embolism patients ( n = 1372, 25.4%) than in non-high-risk pulmonary embolism patients ( n = 134, 2.8%). Multivariable analysis also shows a higher 1-year mortality rate in high-risk pulmonary embolism patients than in non-high-risk pulmonary embolism patients (hazard ratio [HR], 3.98; CI, 3.59-4.40). The 1-year mortality of hospital survivors after hospital discharge is also higher in high-risk pulmonary embolism patients than in non-high-risk pulmonary embolism patients (HR, 1.70; CI, 1.49-1.96).

CONCLUSIONS: This nationwide registry study confirmed that high-risk pulmonary embolism patients have a higher mortality than patients with non-high-risk pulmonary embolism admitted to the ICU. The unfavorable difference in mortality risk persists in the first year after hospital discharge. These numbers should be considered when making management decisions in patients with pulmonary embolism.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Mandigers L, Termorshuizen F, Rietdijk WJR, et al. Short-Term and Long-Term Mortality of Pulmonary Embolism Patients Admitted to the ICU in the Netherlands. Crit Care Med. 2026. PMID: 42262341. doi:10.1097/CCM.0000000000007230

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。